(Q34568308)

3 August 2017

title

CV 205-502, a new dopamine agonist, versus bromocriptine in the treatment of hyperprolactinaemia (English)

1 reference

3 August 2017

CV 205–502, a new dopamine agonist, versus bromocriptine in the treatment of hyperprolactinaemia (English)

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

26 October 2022

author name string

van der Heijden PF

1

1 reference

3 August 2017

de Wit W

2

1 reference

3 August 2017

P. F. van der Heijden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676973

26 October 2022

W. de Wit

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676973

26 October 2022

J. Brownell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676973

26 October 2022

J. Schoemaker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676973

26 October 2022

R. Rolland

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676973

26 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1676973

26 October 2022

publication date

1 July 1991

1 reference

full work available at URL

3 August 2017

https://api.elsevier.com/content/article/PII:002822439190101P?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

https://api.elsevier.com/content/article/PII:002822439190101P?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

European Journal of Obstetrics Gynecology and Reproductive Biology

26 October 2022

published in

1 reference

3 August 2017

volume

40

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

111-118

1 reference

A broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: a study of serum prolactin and bromocriptine levels after acute and chronic admknistration of bromocriptine

3 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

Prolactin and reproduction

26 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

Management of hyperprolactinaemic amenorrhoea

26 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

Drugs five years later. Bromocriptine

26 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

Hyperprolactinemia. Long-term effects of bromocriptine

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

In vivo labeling of brain dopamine D2 receptors using the high-affinity specific D2 agonist [3H]CV 205-502.

26 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

Specific effect of CV 205-502, a potent nonergot dopamine agonist, during a combined anterior pituitary function test

26 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

CV 205-502: a new long-acting drug for inhibition of prolactin hypersecretion

26 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

CV 205-502 treatment of hyperprolactinemia

26 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

The effectiveness, safety, and tolerability of CV 205-502 in hyperprolactinemic women: a 12-month study

26 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

Long-term treatment with a new non-ergot long-acting dopamine agonist, CV 205-502, in women with hyperprolactinaemia.

26 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

Effect of CV 205-502 in hyperprolactinaemic patients intolerant of bromocriptine.

26 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0028-2243(91)90101-P

26 October 2022

Identifiers

1 reference

3 August 2017

1 reference